Globus Medical (GMED) PT Lowered to $70 at Stifel
Stifel analyst Mathew Blackman lowered the price target on Globus Medical (NYSE: GMED) to $70.00 (from $94.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
